{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:07:23Z","timestamp":1792076843228,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI071002"],"award-info":[{"award-number":["AI071002"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1021\/B09"],"award-info":[{"award-number":["CRC1021\/B09"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Measles virus (MeV) is a highly contagious pathogen that enters the human host via the respiratory route. Besides acute pathologies including fever, cough and the characteristic measles rash, the infection of lymphocytes leads to substantial immunosuppression that can exacerbate the outcome of infections with additional pathogens. Despite the availability of effective vaccine prophylaxis, measles outbreaks continue to occur worldwide. We demonstrate that prophylactic and post-exposure therapeutic treatment with an orally bioavailable small-molecule polymerase inhibitor, ERDRP-0519, prevents measles disease in squirrel monkeys (<jats:italic>Saimiri sciureus<\/jats:italic>). Treatment initiation at the onset of clinical signs reduced virus shedding, which may support outbreak control. Results show that this clinical candidate has the potential to alleviate clinical measles and augment measles virus eradication.<\/jats:p>","DOI":"10.1038\/s41467-021-25497-4","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:03:29Z","timestamp":1630577009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding"],"prefix":"10.1038","volume":"12","author":[{"given":"Kevin","family":"Wittwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Pfeffermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0620-1674","authenticated-orcid":false,"given":"Robert M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef D.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Santibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Mankertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Plesker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-1410","authenticated-orcid":false,"given":"Zachary M.","family":"Sticher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Kolkykhalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Natchus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3302-0780","authenticated-orcid":false,"given":"Christian K.","family":"Pfaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2034-2107","authenticated-orcid":false,"given":"Richard K.","family":"Plemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"von Messling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"key":"25497_CR1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nature10639","volume":"480","author":"MD M\u00fchlebach","year":"2011","unstructured":"M\u00fchlebach, M. D. et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 480, 530\u2013533 (2011).","journal-title":"Nature"},{"key":"25497_CR2","doi-asserted-by":"crossref","unstructured":"Laksono, B. M., Vries, R. D. de, McQuaid, S., Duprex, W. P. & Swart, R. L. de. Measles virus host invasion and pathogenesis. Viruses 8, 210 (2016).","DOI":"10.3390\/v8080210"},{"key":"25497_CR3","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1017\/S0950268817002564","volume":"145","author":"AS Mahmud","year":"2017","unstructured":"Mahmud, A. S., Alam, N. & Metcalf, C. J. E. Drivers of measles mortality: the historic fatality burden of famine in Bangladesh. Epidemiol. Infect. 145, 3361\u20133369 (2017).","journal-title":"Epidemiol. Infect."},{"key":"25497_CR4","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.15585\/mmwr.mm6945a6","volume":"69","author":"MK Patel","year":"2020","unstructured":"Patel, M. K. et al. Progress toward regional measles elimination - worldwide, 2000\u20132019. MMWR Morbidity Mortal. Wkly Rep. 69, 1700\u20131705 (2020).","journal-title":"MMWR Morbidity Mortal. Wkly Rep."},{"key":"25497_CR5","doi-asserted-by":"crossref","unstructured":"Petrova, V. N. et al. Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles. Sci. Immunol. 4, eaay6125 (2019).","DOI":"10.1126\/sciimmunol.aay6125"},{"key":"25497_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00430-016-0451-4","volume":"205","author":"H Holzmann","year":"2016","unstructured":"Holzmann, H., Hengel, H., Tenbusch, M. & Doerr, H. W. Eradication of measles: remaining challenges. Med. Microbiol. Immunol. 205, 201\u2013208 (2016).","journal-title":"Med. Microbiol. Immunol."},{"key":"25497_CR7","doi-asserted-by":"publisher","first-page":"A35","DOI":"10.1016\/j.vaccine.2017.10.065","volume":"36","author":"WA Orenstein","year":"2018","unstructured":"Orenstein, W. A. et al. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: background and summary. Vaccine 36, A35\u2013A42 (2018).","journal-title":"Vaccine"},{"key":"25497_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1126\/science.368.6487.116","volume":"368","author":"L Roberts","year":"2020","unstructured":"Roberts, L. Pandemic brings mass vaccinations to a halt. Science 368, 116\u2013117 (2020).","journal-title":"Science"},{"key":"25497_CR9","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1126\/science.7063839","volume":"215","author":"RM Anderson","year":"1982","unstructured":"Anderson, R. M. & May, R. M. Directly transmitted infections diseases: control by vaccination. Science 215, 1053\u20131060 (1982).","journal-title":"Science"},{"key":"25497_CR10","first-page":"811","volume":"10","author":"RK Plemper","year":"2009","unstructured":"Plemper, R. K. & Snyder, J. P. Measles control\u2013can measles virus inhibitors make a difference? Curr. Opin. Investig. Drugs 10, 811\u2013820 (2009).","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"25497_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coviro.2020.02.007","volume":"41","author":"RK Plemper","year":"2020","unstructured":"Plemper, R. K. Measles resurgence and drug development. Curr. Opin. Virol. 41, 8\u201317 (2020).","journal-title":"Curr. Opin. Virol."},{"key":"25497_CR12","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1128\/AAC.00289-07","volume":"51","author":"LK White","year":"2007","unstructured":"White, L. K. et al. Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity. Antimicrob. Agents Chemother. 51, 2293\u20132303 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"25497_CR13","doi-asserted-by":"publisher","first-page":"232ra52","DOI":"10.1126\/scitranslmed.3008517","volume":"6","author":"SA Krumm","year":"2014","unstructured":"Krumm, S. A. et al. An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model. Sci. Transl. Med. 6, 232ra52 (2014).","journal-title":"Sci. Transl. Med."},{"key":"25497_CR14","doi-asserted-by":"crossref","unstructured":"Cox, R. M., Sourimant, J., Govindarajan, M., Natchus, M. G. & Plemper, R. K. Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity. PLoS Pathog. 17, e1009371 (2021).","DOI":"10.1371\/journal.ppat.1009371"},{"key":"25497_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmi.2017.06.030","volume":"23","author":"S Santibanez","year":"2017","unstructured":"Santibanez, S. et al. Molecular surveillance of measles and rubella in the WHO European Region: new challenges in the elimination phase. Clin. Microbiol. Infect. 23, 516\u2013523 (2017).","journal-title":"Clin. Microbiol. Infect."},{"key":"25497_CR16","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1128\/AAC.00503-09","volume":"53","author":"J-J Yoon","year":"2009","unstructured":"Yoon, J.-J. et al. Target analysis of the experimental measles therapeutic AS-136A. Antimicrob. Agents Chemother. 53, 3860\u20133870 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"25497_CR17","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1074\/jbc.REV119.009961","volume":"295","author":"CK Navaratnarajah","year":"2020","unstructured":"Navaratnarajah, C. K., Generous, A. R., Yousaf, I. & Cattaneo, R. Receptor-mediated cell entry of paramyxoviruses: Mechanisms, and consequences for tropism and pathogenesis. J. Biol. Chem. 295, 2771\u20132786 (2020).","journal-title":"J. Biol. Chem."},{"key":"25497_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coviro.2020.03.001","volume":"41","author":"K Ayasoufi","year":"2020","unstructured":"Ayasoufi, K. & Pfaller, C. K. Seek and hide: the manipulating interplay of measles virus with the innate immune system. Curr. Opin. Virol. 41, 18\u201330 (2020).","journal-title":"Curr. Opin. Virol."},{"key":"25497_CR19","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1086\/314993","volume":"180","author":"PG Auwaerter","year":"1999","unstructured":"Auwaerter, P. G. et al. Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J. Infect. Dis. 180, 950\u2013958 (1999).","journal-title":"J. Infect. Dis."},{"key":"25497_CR20","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/jama.2016.1353","volume":"315","author":"VK Phadke","year":"2016","unstructured":"Phadke, V. K., Bednarczyk, R. A., Salmon, D. A. & Omer, S. B. Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis. JAMA 315, 1149\u20131158 (2016).","journal-title":"JAMA"},{"key":"25497_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1517\/17460441.2014.867324","volume":"9","author":"RK Plemper","year":"2014","unstructured":"Plemper, R. K. & Hammond, A. L. Synergizing vaccinations with therapeutics for measles eradication. Expert Opin. Drug Discov. 9, 201\u2013214 (2014).","journal-title":"Expert Opin. Drug Discov."},{"key":"25497_CR22","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1021\/jm201699w","volume":"55","author":"JM Ndungu","year":"2012","unstructured":"Ndungu, J. M. et al. Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: synthesis, structure-activity relationships, and pharmacokinetics. J. Med. Chem. 55, 4220\u20134230 (2012).","journal-title":"J. Med. Chem."},{"key":"25497_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jviromet.2005.10.006","volume":"132","author":"KB Hummel","year":"2006","unstructured":"Hummel, K. B., Lowe, L., Bellini, W. J. & Rota, P. A. Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens. J. Virol. Methods 132, 166\u2013173 (2006).","journal-title":"J. Virol. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25497-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25497-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25497-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T14:09:00Z","timestamp":1669990140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25497-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25497"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25497-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,2]]},"assertion":[{"value":"19 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.K.P. is a co-inventor on US patent US9499489B2, \u201cMyxovirus therapeutics, compounds, and uses related thereto\u201d, which covers composition of matter and the method of use of ERDRP-0519 for measles therapy. This study could affect his personal financial status. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5233"}}